Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT03058029

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Gelesis, Inc. (from the registry)
Registry
  • NCT NCT03058029
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, Czechia, Denmark, Hungary, Italy, Poland, United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03058029. Randomized; triple masking; primary purpose treatment. Start 2017-02-22 (actual); primary completion 2021-01-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes
Acronym
LIGHT-UP
Condition
Overweight
Condition
Diabetes
Condition
PreDiabetes
Condition
Obesity
Intervention (Device)
Gelesis200
Intervention (Device)
Placebo
Lead sponsor
Gelesis, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03058029
Content hash
d348528e774d5e757fee44dbd6aa2af078d9b41d180ea90e70b254c89fd262a6